Gastrooesophageal Reflux Disease
also: Gastroesophageal Reflux Disease
47 drugs47,915 FAERS reportsMedDRA PT
GET
/api/v1/reaction/gastrooesophageal-reflux-diseaseReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D005764
Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
Source: U.S. National Library of Medicine — MeSH (Gastroesophageal Reflux)
Drugs reporting Gastrooesophageal Reflux Disease (47)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Policresulen1100%
- 2Cholecalciferol44214%
- 3Pyrilamine5213%
- 4Levomilnacipran1759.3%
- 5Bexagliflozin28.0%
- 6Magnesium Citrate4627.9%
- 7Tipranavir1017.3%
- 8Botulinum Toxin Type A8497.1%
- 9Asiatic Acid16.7%
- 10Olmesartan2,5445.9%
- 11Ciclesonide7675.7%
- 12Aclidinium3545.6%
- 13Bismuth Subsalicylate3125.5%
- 14Iodoquinol25.3%
- 15Esomeprazole11,9615.1%
- 16Pyridoxine2375.1%
- 17Simethicone4025.0%
- 18Magnesium Hydroxide7804.2%
- 19Magnesium Carbonate3364.2%
- 20Dexbrompheniramine104.2%
- 21Liothyronine3524.1%
- 22Vitamin A2854.1%
- 23Cimetidine3754.0%
- 24Calcium Carbonate2,8003.9%
- 25Phosphorus3733.8%
- 26Nizatidine563.7%
- 27Tretinoin3203.7%
- 28Oxaprozin323.6%
- 29Vonoprazan2393.5%
- 30Dexlansoprazole1,4413.5%
- 31Aluminum Hydroxide2683.4%
- 32Dextran553.2%
- 33Aluminum2783.1%
- 34Sacrosidase53.0%
- 35Mometasone1,8622.9%
- 36Diflorasone52.7%
- 37Cobaltous Chloride12.7%
- 38Exametazime12.6%
- 39Cholic Acid102.5%
- 40Avutometinib132.5%
- 41Defactinib132.5%
- 42Magnesium19,1452.4%
- 43Eliglustat352.3%
- 44Xanomeline382.2%
- 45Hyaluronate172.2%
- 46Zavegepant121.5%
- 47Oxymorphone940.8%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- End Stage Renal Disease7 shared · 0.09
- Renal Injury5 shared · 0.08
- Dyspepsia7 shared · 0.07
- Chronic Kidney Disease14 shared · 0.07
- Abdominal Pain Upper22 shared · 0.06
- Hypoaesthesia6 shared · 0.05
- Asthma6 shared · 0.05
- Throat Irritation3 shared · 0.05
- Taste Disorder3 shared · 0.05
- Renal Failure14 shared · 0.05
Literature
Recent PubMed references pinned to Gastroesophageal Reflux as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Intraoperative gastroesophageal reflux in dogs undergoing mastectomy under opioid-based protocols: a preliminary endoscopic study.Veterinary research communications · 2026 · Dos P, Ribas S, Gurgel HJ, et al.PMID 42201443DOI 10.1007/s11259-026-11290-5
- Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Diagnostic Testing and Clinical Approach Based on the San Diego Consensus.Neurogastroenterology and motility · 2026 · O'Rourke A, Sweis R, Jette M, et al.PMID 42178700DOI 10.1111/nmo.70351
- Timeline for reinitiation of antireflux medication post-surgical or endoscopic antireflux procedures.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2026 · Simadibrata DM, Fass RPMID 42172098DOI 10.1093/dote/doag043
- Elements Affecting Quality of Life in Individuals With Gastroesophagel Reflux Disease.JSLS : Journal of the Society of Laparoendoscopic Surgeons · 2026 · Kong L, Zheng Y, Cui Y, et al.PMID 42164550DOI 10.4293/JSLS.2025.00091
- Substance Use Disorders Are Associated With Increased Long-Term Risks of Gastroesophageal Reflux Disease Phenotypes: A Global Propensity-Matched Cohort Study.Neurogastroenterology and motility · 2026 · Sun Y, Veccia D, Liu B, et al.PMID 42163038DOI 10.1111/nmo.70329
- Gastrostomy plus fundoplication or gastro-jejunal tube or gastrostomy alone for treating or preventing gastro-esophageal reflux in children and adolescents with neurological impairment.The Cochrane database of systematic reviews · 2026 · Flores JC, Campos JM, Gana JC, et al.PMID 42159156DOI 10.1002/14651858.CD015007.pub2
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.